US 11246881
Nanoparticle to target cancer
granted A61KA61K31/7088A61K31/713
Quick answer
US patent 11246881 (Nanoparticle to target cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K31/7088, A61K31/713, A61K47/10, A61K47/183